FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
Source link
Related Posts
This US Navy “Lightning Carrier” Just Sailed Up to China’s Backdoor
The USS Tripoli is not quite an aircraft carrier—but her complement of F-35s…
‘Looks Like He’ll Go to Algeria’: DHS Plans to Rearrest and Deport Columbia Encampment Leader Mahmoud Khalil
DHS plans to rearrest Columbia University encampment leader Mahmoud Khalil and…
Talarico faces backlash for sixth-grader ‘Obama memoirs’ assignment
NEWYou can now listen to Fox News articles! Democrat darling and Texas Senate…
Did Trump use the 'Havana syndrome' weapon on Venezuela?
A Venezuelan security guard, speaking to the New York Post after the January 3…
Cory Booker Ties the Knot with Alexis Lewis — Dual Marriage Ceremonies in NJ & DC
Nov. 30 (UPI) — Sen. Cory Booker married his fiancee, Alexis Lewis, on Sunday in…
The USS Gravely Is Now Home for the Holidays
The Gravely had previously been deployed in the Caribbean—and before that in the…
Bill Maher Lures Adam Schiff Right Into Trap On Trump’s Justification For War In Iran
'Well, Obama made the argument initially that he could go into Syria…
‘Person of Interest’ Detained in Brown University Shooting
A “person of interest” was detained early Sunday morning in connection with the…
Tina Peters Trump pardon request Colorado appeals court judges skeptical
NEWYou can now listen to Fox News articles! A Colorado appeals court appeared…
MacKenzie Scott's Billion-Dollar Bet on Vibes
Every time a MacKenzie Scott grantee talks about receiving one of her…
